Bruce J. Seeley Cti Biopharma Corp (CTIC) insider trading activity

CTIC Quotes by TradingView

Bruce J. Seeley is EVP, Chief Operating Officer of CTI BIOPHARMA CORP. Currently has a direct ownership of 43,905 shares of CTIC, which is worth approximately $399,096. The most recent transaction as insider was on Dec 31, 2021, when has been sold 3,241 shares (Common Stock) at a price of $2.11 per share, resulting in proceeds of $6,839. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.9K
0% 3M change
0% 12M change
Total Value Held $399,096

BRUCE J. SEELEY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2021
BUY
Grant, award, or other acquisition
$6,839 $2.11 p/Share
3,241 Added 6.87%
43,905 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
$6,708 $2.12 p/Share
3,164 Added 7.22%
40,664 Common Stock
Jul 01 2020
BUY
Grant, award, or other acquisition
$4,900 $0.98 p/Share
5,000 Added 11.76%
37,500 Common Stock
BJS

Bruce J. Seeley

EVP, Chief Operating Officer
Seattle, WA

Track Institutional and Insider Activities on CTIC

Follow CTI BIOPHARMA CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTIC shares.

Notify only if

Insider Trading

Get notified when an Cti Biopharma Corp insider buys or sells CTIC shares.

Notify only if

News

Receive news related to CTI BIOPHARMA CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CTIC